Marrone Bio Innovations (MBII) Announces CFO Transition

Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, announced today a transition of its Chief Financial Officer role. Current CFO Sue Cheung has chosen to resign for personal reasons, effective March 9, 2022. LaDon Johnson, a director with CFO Systems, has been appointed interim CFO on a consulting basis while the company begins a national search for a permanent CFO.

“We appreciate Sue’s contributions to Marrone Bio over the past year, and wish her the best,” said Chief Executive Officer Kevin Helash. “I have full confidence in LaDon and our finance organization, and expect the transition to be seamless.”

Mr. Johnson has more than 30 years of experience in global corporate finance in the agriculture, food, renewables and biotechnology sectors. Previous roles include serving as CFO for an international biotechnology company and as Managing Director and CFO for the fifth largest crop seed company in the world.

Helash added, “We welcome LaDon to the company and look forward to gaining from his insights and experience in finance for global agricultural companies during the coming months as we manage the transition and recruit a permanent CFO.”

You May Also Be Interested In

• Gap Inc. names Michael Francis as Old Navy CEO effective November
• Truist names Harold Ford Jr. as Wholesale Banking vice chair
• Mogotes Metals closes $15M Rio Tinto investment and technical alliance